Bumper Offer - Urjas oil Just @ Rs. 1
Pregaba SR 75 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Neuropathic Pain, Epilepsy, Anxiety are some of its major therapeutic uses. Pregaba SR 75 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Pregaba SR 75 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Some other side effects of Pregaba SR 75 Tablet have been listed ahead. These side effects of Pregaba SR 75 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Pregaba SR 75 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Pregaba SR 75 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pregaba SR 75 Tablet related warnings section.
Some other conditions that can be affected by Pregaba SR 75 Tablet are listed in the contraindications section below.
Drug interactions for Pregaba SR 75 Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Pregaba SR 75 Tablet is not safe while driving, and is not addiction.
Pregaba SR 75 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Pregaba SR 75 Tablet is used -
Moderate
Mild
Is the use of Pregaba SR 75 Tablet safe for pregnant women?
Pregaba may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Pregaba again without your doctor's advice.
Is the use of Pregaba SR 75 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pregaba. So it is adviced to consult the doctor before using it.
What is the effect of Pregaba SR 75 Tablet on the Kidneys?
Pregaba rarely harms the kidneys.
What is the effect of Pregaba SR 75 Tablet on the Liver?
Pregaba is completely safe for the liver.
What is the effect of Pregaba SR 75 Tablet on the Heart?
There are no any side effects of Pregaba for the heart.
Pregaba SR 75 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pregaba SR 75 Tablet unless your doctor advises you to do so -
Is this Pregaba SR 75 Tablet habit forming or addictive?
No, you will not get addicted to Pregaba SR 75 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pregaba SR 75 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Pregaba SR 75 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, taking Pregaba SR 75 Tablet can treat mental disorders.
Interaction between Food and Pregaba SR 75 Tablet
Taking Pregaba SR 75 Tablet with food does not cause any problems.
Interaction between Alcohol and Pregaba SR 75 Tablet
Taking alcohol with Pregaba SR 75 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
